Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Inflammopharmacology
|
July 13, 2022
Effect of aqueous extract of seed of broccoli on inflammatory cytokines and Helicobacter pylori infection: a randomized, double-blind, controlled trial in patients without atrophic gastritis
Kai Guo, Lei Wang, Jinli Mahe, et al.
Nanoscale Research Letters
|
October 10, 2013
ZnO nanoneedle/H2O solid-liquid heterojunction-based self-powered ultraviolet detector
Qinghao Li, Lin Wei, Yanru Xie, et al.
Optics Express
|
April 6, 2021
Observation of split evanescent field distributions in tapered multicore fibers for multiline nanoparticle trapping and microsensing
Dong Yan, Zhen Tian, Nan-Kuang Chen, et al.
Current Biology : CB
|
January 25, 2024
The mechanism underlying asymmetric bending of lateral petals in Delphinium (Ranunculaceae)
Hanghang Zhang, Fang Xue, Liping Guo, et al.
The Oncologist
|
February 17, 2024
Apatinib Plus Toripalimab (Anti-PD1 Therapy) as Second-Line Therapy in Patients With Advanced Gastric or Esophagogastric Junction Cancer: Results From a Randomized, Open-Label Phase II Study
Qing Wei, Xiaoqing Xu, Jingjing Li, et al.
The Plant Cell
|
December 23, 2022
Delphinieae flowers originated from the rewiring of interactions between duplicated and diversified floral organ identity and symmetry genes
Huiqi Zhao, Hong Liao, Shuixian Li, et al.
Cancer Immunology, Immunotherapy : CII
|
February 15, 2022
Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers
Yulong Zheng, Anna Rachelle Austria Mislang, Jermaine Coward, et al.
BMC Medicine
|
July 22, 2025
Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of chemoimmunotherapy in advanced unresectable biliary tract cancers
Jiaojiao Ni, Chaoqun Li, Xiaoqing Xu, et al.
Journal of Hepatology
|
July 6, 2026
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial
Qi Xu, Shurui Zhou, Chenbo Zhang, et al.
Eclinicalmedicine
|
May 27, 2024
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study
Zhihao Lu, Li Kong, Buhai Wang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Inflammopharmacology
|
July 13, 2022
Effect of aqueous extract of seed of broccoli on inflammatory cytokines and Helicobacter pylori infection: a randomized, double-blind, controlled trial in patients without atrophic gastritis
Kai Guo, Lei Wang, Jinli Mahe, et al.
Nanoscale Research Letters
|
October 10, 2013
ZnO nanoneedle/H2O solid-liquid heterojunction-based self-powered ultraviolet detector
Qinghao Li, Lin Wei, Yanru Xie, et al.
Optics Express
|
April 6, 2021
Observation of split evanescent field distributions in tapered multicore fibers for multiline nanoparticle trapping and microsensing
Dong Yan, Zhen Tian, Nan-Kuang Chen, et al.
Current Biology : CB
|
January 25, 2024
The mechanism underlying asymmetric bending of lateral petals in Delphinium (Ranunculaceae)
Hanghang Zhang, Fang Xue, Liping Guo, et al.
The Oncologist
|
February 17, 2024
Apatinib Plus Toripalimab (Anti-PD1 Therapy) as Second-Line Therapy in Patients With Advanced Gastric or Esophagogastric Junction Cancer: Results From a Randomized, Open-Label Phase II Study
Qing Wei, Xiaoqing Xu, Jingjing Li, et al.
The Plant Cell
|
December 23, 2022
Delphinieae flowers originated from the rewiring of interactions between duplicated and diversified floral organ identity and symmetry genes
Huiqi Zhao, Hong Liao, Shuixian Li, et al.
Cancer Immunology, Immunotherapy : CII
|
February 15, 2022
Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers
Yulong Zheng, Anna Rachelle Austria Mislang, Jermaine Coward, et al.
BMC Medicine
|
July 22, 2025
Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of chemoimmunotherapy in advanced unresectable biliary tract cancers
Jiaojiao Ni, Chaoqun Li, Xiaoqing Xu, et al.
Journal of Hepatology
|
July 6, 2026
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial
Qi Xu, Shurui Zhou, Chenbo Zhang, et al.
Eclinicalmedicine
|
May 27, 2024
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study
Zhihao Lu, Li Kong, Buhai Wang, et al.
Page
of 4